NCT06367569View on ClinicalTrials.gov

Evaluation of MRI of the Pineal Gland in Retinoblastoma

CompletedOBSERVATIONAL
Enrollment

607

Participants

Timeline

Start Date

October 1, 2012

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2023

Conditions
Retinoblastoma
Interventions
DIAGNOSTIC_TEST

Screening for trilateral retinoblastoma with MRI

The diagnostic accuracy of the screening program, baseline screening with MRI followed by follow-up of suspicious pineal glands in heritable retinoblastoma patients.

Trial Locations (1)

1081 HV

VU University Medical Center, Amsterdam

All Listed Sponsors
lead

Amsterdam UMC, location VUmc

OTHER

NCT06367569 - Evaluation of MRI of the Pineal Gland in Retinoblastoma | Biotech Hunter | Biotech Hunter